• Impact of a Daily Application of an Omega-3 Monoglycerides Based Serum and Cream on the Skin Microbiota

  NCT07583121

  Not yet recruitingInterventionalNot ApplicableUpdated May 13, 2026
• Efficacy of Gel With Ecological Extra Virgin Olive Oil in Peristomal Skin Hygiene

  NCT05289765

  CompletedInterventionalNot ApplicableUpdated Feb 28, 2023
• Stria Gravidarum and Olive Oil for Pregnancy Women

  NCT04489901

  CompletedInterventionalNot ApplicableUpdated Jul 28, 2020
• Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO)

  NCT05413395

  Unknown statusInterventionalNot ApplicableUpdated Jul 5, 2022
• Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

  NCT06155513

  TerminatedInterventionalNot ApplicableUpdated Apr 22, 2026
• Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients

  NCT05285943

  CompletedInterventionalPhase 4Updated Feb 12, 2025

ClinicalTrials.gov ID

NCT00421161

Lead Sponsor

Assaf-Harofeh Medical CenterOTHER_GOV

Overall Status

Unknown status

Study Type

Interventional

Phase

Phase 1Phase 2

Enrollment

30

Last Update Posted

Jan 11, 2007Estimated

Start Date

Jan 2007

Completion Date

Mar 2007

Official Title

Phase 1 and 2 Study on the Efficacy and Side Effects of Olive Oil and Omega 3 Local Treatment in Stasis Dermatitis

Brief Summary

Olive oil and Omega 3 have many anti inflammatory effects that may be beneficial in the inflammation and edema of chronic stasis dermatitis. The olive oil contains many mono unsaturated fatty acids and anti oxidants that may add to the well being of a diseased skin by improving cell membrane homeostasis.

Detailed Description

Patients with chronic stasis dermatitis due to venous insufficiency will be treated with the study cream and as control we will use "Venoroutone" . Patients will be followed weekly at the clinic of the vascular surgery at Assaf Harofeh MC.

• Dermatitis

• olive oil and omega 3 in a combined cream

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Patints with stasis dermatitis for 6 months at least

Exclusion Criteria:

• skin ulceration or infection

Primary Purpose

Treatment

Allocation

Randomized

Interventional Model

Single Group Assignment

Masking

Double

Lead Sponsor

Assaf-Harofeh Medical CenterOTHER_GOV

rsegal@post.tau.ac.il972-8-9258640-3